Prof. Umut Kefeli
5
reviews
We started chemotherapy. Your confident manner, which shows that you know your work, helped us feel better. You do everything in your power, the rest is in God's hands. We hope to recover.
09/01/2021
27/02/2015
12/10/2014
18/08/2014
14/07/2014
Professor Umut Kefeli is a medical oncologist at the Faculty of Medicine of Kocaeli University, a specialist in internal medicine and clinical oncology. He has over 20 years of professional experience.
He teaches and treats patients in the Department of Internal Medicine (Oncology Division) at Kocaeli University. He actively participates in international research projects and is a member of ESMO and ASCO. He is the author of more than 130 scientific publications (h-index 15 on WoS/Scopus, 18 on Google Scholar; over 900 citations).
Areas of expertise: drug therapy for colorectal, breast, lung, gastric and prostate cancer, neuroendocrine tumors, immunotherapy, targeted therapy, telemedicine in oncology, prognostic biomarkers (neutrophil-to-lymphocyte ratio, albumin/alkaline phosphatase).
Co-author of works on the use of Lutetium-177 PSMA-617 in prostate cancer, the efficacy of capecitabine and temozolomide in neuroendocrine tumors, and palliative colorectal stenting. He has led 28 research projects.
Achievements and awards
About Dr. Umut Kefeli
- Drug therapy for cancer (medical oncology)
- Colorectal cancer
- Breast cancer
- Lung cancer
- Stomach and esophageal cancer
- Prostate cancer, including Lutetium-177 PSMA-617 therapy
- Neuroendocrine tumors
- Targeted therapy and immunotherapy
- Prognostic biomarkers in oncology
- Higher medical education, Faculty of Medicine (Turkey), MD degree
- Residency in internal medicine
- Subspecialty in medical oncology
- Awarded the titles of Associate Professor and Professor at the Faculty of Medicine of Kocaeli University
- Professor in the Department of Internal Medicine (Medical Oncology Division), Faculty of Medicine, Kocaeli University
- Drug therapy for patients with cancer
- Participation in multidisciplinary oncology tumor boards
- Teaching of students and residents
- Author of more than 130 scientific publications. WoS and Scopus h-index — 15, Google Scholar h-index — 18, over 900 total citations. Lead investigator of 28 research projects.
- Co-author of international works on Lutetium-177 PSMA-617 therapy for metastatic castration-resistant prostate cancer
- Studies on the efficacy of capecitabine and temozolomide combination in neuroendocrine tumors
- Works on the prognostic role of the neutrophil-to-lymphocyte ratio and albumin/alkaline phosphatase in oncology
- Studies on the perception and adoption of telemedicine by medical oncologists in Turkey (COVID-19)
- Publications on colorectal stenting for palliation and preparation for surgery
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Turkish Society of Medical Oncology (TTOD)
- Turkish Oncology Group (TOG)
Kocaeli University Hospital is an academic medical complex affiliated with the Faculty of Medicine of Kocaeli University, located in İzmit. It is one of the largest state university hospitals in northwestern Turkey.
The hospital provides a full range of diagnostic and therapeutic care in oncology, surgery, cardiology, neurology, and transplantation. The Medical Oncology Department is equipped with state-of-the-art systems for drug therapy, immunotherapy and targeted therapy, and conducts clinical research.
The clinic combines a university research base with clinical practice, providing patients access to the latest treatment protocols and innovative drugs.
